A review of the analysis of tobacco-specific nitrosamines in biological matrices

References

• Adams JD, Brunnemann KD, Hoffmann D (1983). Chemical studies on tobacco smoke: LXXV. Rapid method for the analysis of tobacco-specific N-nitrosamines by gas–liquid chromatography with a thermal energy analyser. J Chromatogr A 256:347–351.
   Web of Science ®Google Scholar
• American Cancer Society (2009). Cancer Facts and Figures. June 2009.
   Google Scholar
• Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, Hecht SS (2001). Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. J Natl Cancer Inst. 93:378–381.
   PubMed Web of Science ®Google Scholar
• Anderson KE, Kliris J, Murphy L, Carmella SG, Han S, Link C, Bliss RL, Puumala S, Murphy SE, Hecht SS (2003). Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons. Cancer Epidemiol Biomarkers Prev. 12:1544–1546.
   PubMed Web of Science ®Google Scholar
• Annesley TM (2003). Ion suppression in mass spectrometry. Clin Chem. 49:1041–1044.
   PubMed Web of Science ®Google Scholar
• Avery MJ (2003). Quantitative characterization of differential ion suppression on liquid chromatography/atmospheric pressure ionization mass spectrometric bioanalytical methods. Rapid Commun Mass Spectrom. 17:197–201.
   PubMed Web of Science ®Google Scholar
• Bartsch H (1996). DNA adducts in human carcinogenesis: Etiological relevance and structure-activity relationship. Mutat Res. 340:67–79.
   PubMed Web of Science ®Google Scholar
• Beveridge A (1998). Forensic Investigation of Explosions. London: Taylor & Francis.
   Google Scholar
• Blau K, Halket JM, eds. (1993). Handbook of Derivatives for Chromatography. 2nd ed. New York: Wiley.
   Google Scholar
• Bonfiglio R, King RC, Olah TV, Merkle K (1999). The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun Mass Spectrom. 13:1175–1185.
   PubMed Web of Science ®Google Scholar
• Brittebo E, Tjalve H (1980). Autoradiographic observations on the distribution and metabolism of N’-/14C/nitrosonornicotine in mice. J Cancer Res Clin Oncol. 98:233–242.
   PubMed Web of Science ®Google Scholar
• Brittebo EB, Tjalve H (1981). Formation of tissue-bound N’-nitrosonornicotine metabolites by the target tissues of Sprague-Dawley and Fisher rats. Carcinogenesis. 2:959–963.
   PubMed Web of Science ®Google Scholar
• Brunnemann KD, Hoffmann D (1981). Assessment of the carcinogenic N-nitrosodiethanolamine in tobacco products and tobacco smoke. Carcinogenesis. 2:1123–1127.
   PubMed Web of Science ®Google Scholar
• Brunnemann KD, Genoble L, Hoffmann D (1987). Identification and analysis of a new tobacco-specific N-nitrosamine, 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol. Carcinogenesis. 8:465–469.
   PubMed Web of Science ®Google Scholar
• Brunnemann KD, Hoffmann D (1991). Analytical studies on tobacco-specific N-nitrosamines in tobacco and tobacco smoke. Crit Rev Toxicol. 21:235–240.
   PubMed Web of Science ®Google Scholar
• Brunnemann KD, Cox JE, Hoffmann D (1992). Analysis of tobacco-specific N-nitrosamines in indoor air. Carcinogenesis. 13:2415–2418.
   PubMed Web of Science ®Google Scholar
• Byrd GD, Ogden M. W (2003). Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers’ urine. J Mass Spectrom. 38:98–107.
   PubMed Web of Science ®Google Scholar
• Campo VL, Bernardes LS, Carvalho I (2009). Stereoselectivity in drug metabolism: molecular mechanisms and analytical methods. Curr Drug Metab. 10:188–205.
   PubMed Web of Science ®Google Scholar
• Carmella SG, Akerkar S, Hecht SS (1993a). Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers’ urine. Cancer Res. 53:721–724.
   PubMed Web of Science ®Google Scholar
• Carmella SG, Akerkar SA, Richie JP Jr, Hecht SS (1995). Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers’ urine. Cancer Epidemiol Biomarkers Prev. 4:635–642.
   PubMed Web of Science ®Google Scholar
• Carmella SG, Borukhova A, Akerkar SA, Hecht SS (1997). Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen. Cancer Epidemiol Biomarkers Prev. 6:113–120.
   PubMed Web of Science ®Google Scholar
• Carmella SG, Ye M, Upadhyaya P, Hecht SS (1999). Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers’ urine. Cancer Res. 59:3602–3605.
   PubMed Web of Science ®Google Scholar
• Carmella SG, Le Ka KA, Upadhyaya P, Hecht SS (2002). Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Chem Res Toxicol. 15:545–550.
   PubMed Web of Science ®Google Scholar
• Carmella SG, Han S, Fristad A, Yang Y, Hecht SS (2003). Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Cancer Epidemiol Biomarkers Prev. 12(11 Pt 1):1257–1261.
   PubMed Web of Science ®Google Scholar
• Carmella SG, Han S, Villalta PW, Hecht SS (2005). Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers’ blood. Cancer Epidemiol Biomarkers Prev. 14(11 Pt 1):2669–2672.
   PubMed Web of Science ®Google Scholar
• Carmella SG, Yoder A, Hecht SS (2006). Combined analysis of r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers’ plasma. Cancer Epidemiol Biomarkers Prev. 15:1490–1494.
   PubMed Web of Science ®Google Scholar
• Carmella SG, Chen M, Han S, Briggs A, Jensen J, Hatsukami DK, Hecht SS (2009). Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol. 22:734–741.
   PubMed Web of Science ®Google Scholar
• Castonguay A, Lin D, Stoner GD, Radok P, Furuya K, Hecht SS, Schut HA, Klaunig JE (1983a). Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N’-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, their analogues. Cancer Res. 43:1223–1229.
   PubMed Web of Science ®Google Scholar
• Castonguay A, Tjalve H, Hecht SS (1983b). Tissue distribution of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its metabolites in F344 rats. Cancer Res. 43:630–638.
   PubMed Web of Science ®Google Scholar
• Castonguay A, Tjalve H, Trushin N, Hecht SS (1984). Perinatal metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in C57BL mice. J Natl Cancer Inst. 72:1117–1126.
   PubMed Web of Science ®Google Scholar
• Castonguay A, Tjalve H, Trushin N, d’Argy R, Sperber G (1985). Metabolism and tissue distribution of tobacco-specific N-nitrosamines in the marmoset monkey (Callithrix jacchus). Carcinogenesis. 6:1543–1550.
   PubMed Web of Science ®Google Scholar
• Chen Y, Guo Z, Wang X, Qiu C (2008). Sample preparation. J Chromatogr A. 1184:191–219.
   PubMed Web of Science ®Google Scholar
• Church TR, Anderson KE, Caporaso NE, Geisser MS, Le CT, Zhang Y, Benoit AR, Carmella SG, Hecht SS (2009). A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev. 18:260–266.
   PubMed Web of Science ®Google Scholar
• Curfman GD, Morrissey S, Drazen JM (2009). Tobacco, public health, and the FDA. N Engl J Med. 361:402–403.
   PubMed Web of Science ®Google Scholar
• De Bont R, van Larebeke N (2004). Endogenous DNA damage in humans: A review of quantitative data. Mutagenesis. 19:169–185.
   PubMed Web of Science ®Google Scholar
• Dejaegher B, Mangelings D, Vander Heyden Y, (2008). Method development for HILIC assays. J Sep Sci. 31:1438–1448.
   PubMed Web of Science ®Google Scholar
• Djordjevic MV, Brunnemann KD, Hoffmann D (1989). Identification and analysis of a nicotine-derived N-nitrosamino acid and other nitrosamino acids in tobacco. Carcinogenesis. 10:1725–1731.
   PubMed Web of Science ®Google Scholar
• Djordjevic MV, Sigountos CW, Brunnemann KD, Hoffmann D (1991). Formation of 4-(methylnitrosamino)-1-(3-pyridyl) butyric acid in vitro and in mainstream cigarette smoke. J Agric Food Chem. 39:209–213.
   Web of Science ®Google Scholar
• Evans G (2004). A Handbook of Bioanalysis and Drug Metabolism. Boca Raton, FL, London: CRC Press.
   Google Scholar
• Falter B, Kutzer C, Richter E (1994). Biomonitoring of hemoglobin adducts: Aromatic amines and tobacco-specific nitrosamines. Clin Invest 72:364–371.
   PubMedGoogle Scholar
• Fine DH, Rufeh F, Gunther B (1973). A group specific procedure for the analysis of both volatile and nonvolatile N-nitroso compounds in picogram amounts. Anal Lett 6:731 - 733.
   Web of Science ®Google Scholar
• Fine DH, Rufeh F, Lieb D (1974). Group analysis of volatile and non-volatile N-nitroso compounds. Nature. 247:309–310.
   PubMed Web of Science ®Google Scholar
• Fine DH, Lieb D, Rufeh F (1975a). Principle of operation of the thermal energy analyzer for the trace analysis of volatile and non-volatile N-nitroso compounds. J Chromatogr. 107:351–357.
   PubMed Web of Science ®Google Scholar
• Fine DH, Rufeh F, Lieb D, Rounbehler DP (1975b). Description of the thermal energy analyzer (TEA) for trace determination of volatile and nonvolatile N-nitroso compounds. Anal Chem. 47:1188–1191.
   PubMed Web of Science ®Google Scholar
• Fischer S, Spiegelhalder B, Preussmann R (1989). Preformed tobacco-specific nitrosamines in tobacco—role of nitrate and influence of tobacco type. Carcinogenesis. 10:1511–1517.
   PubMed Web of Science ®Google Scholar
• Foiles PG, Akerkar SA, Carmella SG, Kagan M, Stoner GD, Resau JH, Hecht SS (1991). Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem Res Toxicol. 4:364–368.
   PubMed Web of Science ®Google Scholar
• Fu I, Woolf EJ, Matuszewski BK (1998). Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection. J Pharm Biomed Anal. 18:347–357.
   PubMed Web of Science ®Google Scholar
• Hatsukami DK, Lemmonds C, Zhang Y, Murphy SE, Le C, Carmella SG, Hecht SS (2004). Evaluation of carcinogen exposure in people who used “reduced exposure” tobacco products. J Natl Cancer Inst. 96:844–852.
   PubMedGoogle Scholar
• Hecht SS (1998a). Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 11:559–603.
   PubMed Web of Science ®Google Scholar
• Hecht SS (1998b). In:Rom WN, ed. Environmental and Occupational Medicine. N-Nitrosamines New York: Lippincott-Raven, 1479–1499.
   Google Scholar
• Hecht S. S (1999). Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 91:1194–1210.
   PubMed Web of Science ®Google Scholar
• Hecht SS (2002). Human urinary carcinogen metabolites: Biomarkers for investigating tobacco and cancer. Carcinogenesis. 23:907–922.
   PubMed Web of Science ®Google Scholar
• Hecht SS (2003). Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 3:733–744.
   PubMed Web of Science ®Google Scholar
• Hecht SS (2008). Progress and challenges in selected areas of tobacco carcinogenesis. Chem Res Toxicol. 21:160–171.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Hoffmann D (1988). Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 9:875–884.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Rivenson A, Braley J, DiBello J, Adams JD, Hoffmann D (1986). Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res. 46:4162–4166.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Murphy SE, Akerkar S, Brunnemann KD, Hoffmann D (1993a). A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med. 329:1543–1546.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Trushin N, Reid-Quinn CA, Burak ES, Jones AB, Southers JL, Gombar CT, Carmella SG, Anderson LM, Rice JM (1993b). Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: Pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis. 14:229–236.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Chung FL, Richie JP Jr, Akerkar SA, Borukhova A, Skowronski L, Carmella SG (1995). Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol Biomarkers Prev. 4:877–884.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Chen M, Dor Koch JF, Miller AT, Murphy SE, Jensen JA, Zimmerman CL, Hatsukami DK (1999). Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 59:590–596.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Ye M, Carmella SG, Fredrickson A, Adgate JL, Greaves IA, Church TR, Ryan AD, Mongin SJ, Sexton K (2001). Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiol Biomarkers Prev. 10:1109–1116.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Ye M, Le KA, Jensen JA, Zimmerman CL, Hatsukami DK (2002). Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Res. 62:129–134.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Kenney PM, Low SH, Arakawa K, Yu MC (2004a). Effects of cruciferous vegetable consumption on urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in singapore chinese. Cancer Epidemiol Biomarkers Prev. 13:997–1004.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Murphy SE, Carmella SG, Zimmerman CL, Losey L, Kramarczuk I, Roe MR, Puumala SS, Li YS, Le C, Jensen J, Hatsukami DK (2004b). Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. J Natl Cancer Inst. 96:107–115.
   PubMedGoogle Scholar
• Hecht SS, Carmella SG, Le KA, Murphy SE, Boettcher AJ, Le C, Koopmeiners J, An L, Hennrikus DJ (2006). 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides in the urine of infants exposed to environmental tobacco smoke. Cancer Epidemiol Biomarkers Prev. 15:988–992.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Murphy SE, Riley WT, Le C, Luo X, Mooney M, Hatsukami DK (2007). Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomarkers Prev. 16:1567–1572.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Edmonds A, Murphy SE, Stepanov I, Luo X, Hatsukami DK (2008). Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco. Tob Control. 17:128–131.
   PubMed Web of Science ®Google Scholar
• Henry MC, Yonker C. R (2006). Supercritical fluid chromatography, pressurized liquid extraction, and supercritical fluid extraction. Anal Chem. 78:3909–3916.
   PubMed Web of Science ®Google Scholar
• Hoffmann D, Adams JD (1981). Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers. Cancer Res. 41(11 Pt 1):4305–4308.
   PubMed Web of Science ®Google Scholar
• Hoffmann D, Adams JD, Brunnemann KD, Hecht SS (1979). Assessment of tobacco-specific N-nitrosamines in tobacco products. Cancer Res. 39(7 Pt 1):2505–2509.
   PubMed Web of Science ®Google Scholar
• Hoffmann D, Adams JD, Brunnemann KD, Rivenson A, Hecht SS (1982). Tobacco specific N-nitrosamines: occurrence and bioassays. IARC Sci Publ. 41:309–318.
   Google Scholar
• Hoffmann D, Adams JD, Lisk D, Fisenne I, Brunnemann KD (1987). Toxic and carcinogenic agents in dry and moist snuff. J Natl Cancer Inst. 79:1281–1286.
   PubMedGoogle Scholar
• Hoffmann D, Brunnemann KD, Prokopczyk B, Djordjevic MV (1994). Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: Chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health. 41:1–52.
   PubMed Web of Science ®Google Scholar
• Hoffmann D, Djordjevic MV, Fan J, Zang E, Glynn T, Connolly GN (1995). Five leading U.S. commercial brands of moist snuff in 1994: Assessment of carcinogenic N-nitrosamines. J Natl Cancer Inst. 87:1862–1869.
   PubMedGoogle Scholar
• Hoffmann D, Hoffmann I, El-Bayoumy K (2001). The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol. 14:767–790.
   PubMed Web of Science ®Google Scholar
• Hsieh Y (2008). Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites. J Sep Sci. 31:1481–1491.
   PubMed Web of Science ®Google Scholar
• Hurt RD, Croghan GA, Wolter TD, Croghan IT, Offord KP, Williams GM, Djordjevic MV, Richie JP Jr, Jeffrey AM (2000). Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine Tob Res 2:327–336.
   PubMedGoogle Scholar
• International Agency for Research on Cancer (1985). Tobacco habits other than smoking: betel quid and areca nut chewing and some related nitrosamines. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon, France: IARC, 37:37–140.
   Google Scholar
• International Agency for Research on Cancer (1995). Occurence of and exposure to N-nitroso compounds in tobacco. In: Relevance to Human Cancer of N-nitroso Compounds, Tobacco Smoke and Mycotoxins. Lyon, France: IARC, 493–495.
   Google Scholar
• International Agency for Research on Cancer (2002). Tobacco smoke and involuntary smoking. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: IARC, 83:1012–1065.
   Google Scholar
• International Agency for Research on Cancer (2007). Smokeless tobacco and some tobacco-specific nitrosamines. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: IARC, 89:166–370.
   Google Scholar
• Jacob P 3rd, Havel C, Lee DH, Yu L, Eisner MD, Benowitz NL (2008). Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Anal Chem. 80:8115–8121.
   PubMed Web of Science ®Google Scholar
• Jemal M (2000). High-throughput quantitative bioanalysis by LC/MS/MS. Biomed Chromatogr. 14:422–429.
   PubMed Web of Science ®Google Scholar
• Jemal M, Xia YQ (2006). LC-MS Development strategies for quantitative bioanalysis. Curr Drug Metab. 7:491–502.
   PubMed Web of Science ®Google Scholar
• Joseph AM, Hecht SS, Murphy SE, Carmella SG, Le CT, Zhang Y, Han S, Hatsukami DK (2005). Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev. 14:2963–2968.
   PubMed Web of Science ®Google Scholar
• Kavvadias D, Scherer G, Urban M, Cheung F, Errington G, Shepperd J, McEwan M (2009). Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine. J Chromatogr B Analyt Technol Biomed Life Sci. 877:1185–1192.
   PubMed Web of Science ®Google Scholar
• King R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C, Olah T (2000). Mechanistic investigation of ionization suppression in electrospray ionization. J Am Soc Mass Spectrom. 11:942–950.
   PubMed Web of Science ®Google Scholar
• Kresty LA, Carmella SG, Borukhova A, Akerkar SA, Gopalakrishnan R, Harris RE, Stoner GD, Hecht SS (1996). Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: Relationship between urinary biomarkers and oral leukoplakia. Cancer Epidemiol Biomarkers Prev. 5:521–525.
   PubMed Web of Science ®Google Scholar
• Lackmann GM, Salzberger U, Tollner U, Chen M, Carmella SG, Hecht SS (1999). Metabolites of a tobacco-specific carcinogen in urine from newborns. J Natl Cancer Inst. 91:459–465.
   PubMed Web of Science ®Google Scholar
• Lagerwerf FM, van Dongen WD, Steenvoorden RJJM, Honing M, Jonkman JHG (2000). Exploring the boundaries of bioanalytical quantitative LC-MS-MS. Trends Anal Chem 19:418–427.
   Web of Science ®Google Scholar
• Lasakova M, Jandera P (2009). Molecularly imprinted polymers and their application in solid phase extraction. J Sep Sci. 32:799–812.
   PubMed Web of Science ®Google Scholar
• Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003). Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 75:3019–3030.
   PubMed Web of Science ®Google Scholar
• Mazzeo JR, D.,?Neue U, Kele M, Plumb RS (2005). Advancing LC performance with smaller particles and higher pressure. Anal Chem 77:460A–467A.
   Web of Science ®Google Scholar
• Meger M, Richter E, Zwickenpflug W, Oehlmann C, Hargaden MB, YI AR, Vesell ES (1999). Metabolism and disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone (NNK) in rhesus monkeys. Drug Metab Dispos. 27:471–478.
   PubMed Web of Science ®Google Scholar
• Meulemans A, Delsenne F (1994). Measurement of nitrite and nitrate levels in biological samples by capillary electrophoresis. J Chromatogr B Biomed Appl. 660:401–404.
   PubMed Web of Science ®Google Scholar
• Milunsky A, Carmella SG, Ye M, Hecht SS (2000). A tobacco-specific carcinogen in the fetus. Prenat Diagn. 20:307–310.
   PubMed Web of Science ®Google Scholar
• Morcos E, Wiklund N. P (2001). Nitrite and nitrate measurement in human urine by capillary electrophoresis. Electrophoresis. 22:2763–2768.
   PubMed Web of Science ®Google Scholar
• Morse MA, Eklind KI, Toussaint M, Amin SG, Chung FL (1990). Characterization of a glucuronide metabolite of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis. 11:1819–1823.
   PubMed Web of Science ®Google Scholar
• Murphy SE, Carmella SG, Idris AM, Hoffmann D (1994). Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. Cancer Epidemiol Biomarkers Prev. 3:423–428.
   PubMed Web of Science ®Google Scholar
• Murphy SE, Link CA, Jensen J, Le C, Puumala SS, Hecht SS, Carmella SG, Losey L, Hatsukami DK (2004). A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers. Cancer Epidemiol Biomarkers Prev. 13:1617–1623.
   PubMed Web of Science ®Google Scholar
• Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP Jr (2005). Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer. 103:1420–1426.
   PubMed Web of Science ®Google Scholar
• Nair J, Ohshima H, Friesen M, Croisy A, Bhide SV, Bartsch H (1985). Tobacco-specific and betel nut-specific N-nitroso compounds: Occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis. 6:295–303.
   PubMed Web of Science ®Google Scholar
• Pan J, Song Q, Shi H, King M, Junga H, Zhou S, Naidong W (2004). Development, validation and transfer of a hydrophilic interaction liquid chromatography/tandem mass spectrometric method for the analysis of the tobacco-specific nitrosamine metabolite NNAL in human plasma at low picogram per milliliter concentrations. Rapid Commun Mass Spectrom. 18:2549–2557.
   PubMed Web of Science ®Google Scholar
• Parsons WD, Carmella SG, Akerkar S, Bonilla LE, Hecht SS (1998). A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the urine of hospital workers exposed to environmental tobacco smoke. Cancer Epidemiol Biomarkers Prev. 7:257–260.
   PubMed Web of Science ®Google Scholar
• Phillips DH (1996). DNA adducts in human tissues: Biomarkers of exposure to carcinogens in tobacco smoke. Environ Health Perspect. 104(Suppl 3):453–458.
   PubMed Web of Science ®Google Scholar
• Pichon V (2007). Selective sample treatment using molecularly imprinted polymers. J Chromatogr A. 1152:41–53.
   PubMed Web of Science ®Google Scholar
• Poirier MC, Weston A (1996). Human DNA adduct measurements: state of the art. Environ Health Perspect. 104(Suppl 5):883–893.
   PubMed Web of Science ®Google Scholar
• Poirier MC, Santella RM, Weston A (2000). Carcinogen macromolecular adducts and their measurement. Carcinogenesis. 21:353–359.
   PubMed Web of Science ®Google Scholar
• Prokopczyk B, Wu M, Cox JE, Amin S, Desai D (1995). Improved methodology for the quantitative assessment of tobacco specific N-nitrosamines in tobacco by supercritical fluid extraction. J Agric Food Chem. 43:916–922.
   Web of Science ®Google Scholar
• Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE (1997). Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst. 89:868–873.
   PubMedGoogle Scholar
• Prokopczyk B, Hoffmann D, Bologna M, Cunningham A. J, Trushin N, Akerkar S, Boyiri T, Amin S, Desai D, Colosimo S, Pittman B, Leder G, Ramadani M, Henne-Bruns D, Beger HG, El-Bayoumy K (2002). Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol. 15:677–685.
   PubMed Web of Science ®Google Scholar
• Richie JP Jr, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS (1997). Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev. 6:783–790.
   PubMed Web of Science ®Google Scholar
• Richter E, Engl J, Friesenegger S, Tricker AR (2009). Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man. Chem Res Toxicol. 22:1008–1017.
   PubMed Web of Science ®Google Scholar
• Rodgman A, Perfetti TA (2009) The Chemical Components of Tobacco and Tobacco Smoke. Boca Raton, FL, London: CRC Press.
   Google Scholar
• Schaffler G, Betz C, Richter E (1993). Mass spectrometric analysis of tobacco-specific hemoglobin adducts. Environ Health Perspect. 99:187–189.
   PubMed Web of Science ®Google Scholar
• Scherer G, Engl J, Urban M, Gilch G, Janket D, Riedel K (2007). Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul Toxicol Pharmacol. 47:171–183.
   PubMed Web of Science ®Google Scholar
• Shah K, Peoples MC, Halquist MS, James JR, Karnes HT (2009a). Online coupling of molecularly imprinted polymeric micro-column with tandem MS for analysis of a urinary tobacco specific nitrosamine by direct injection. Presented at the 2009 Joint Conference of SRNT and SRNT-Europe, April 27–30, Dublin, Ireland.
   Google Scholar
• Shah K, Peoples M. C, Halquist MS, Karnes HT (2009b). On-line microfluidic extraction using molecularly imprinted polymers for analysis of urinary tobacco specific nitrosamines. Presented at the 2009 AAPS Annual Meeting and Exposition, November 8–12, Los Angeles, CA, USA.
   Google Scholar
• Shah KA, Halquist MS, Karnes HT (2009c). A modified method for the determination of tobacco specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine by solid phase extraction using a molecularly imprinted polymer and liquid chromatography tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 877:1575–1582.
   PubMed Web of Science ®Google Scholar
• Shargel L, Yu ABC (1999). Applied Biopharmaceutics and Pharmacokinetics. 4th ed. Stamford, CT: Appleton & Lange.
   Google Scholar
• Smith RM (1999). Supercritical fluids in separation science—The dreams, the reality and the future. J Chromatogr A. 856:83–115.
   PubMed Web of Science ®Google Scholar
• Spiegelhalder B, Bartsch H (1996). Tobacco-specific nitrosamines. Eur J Cancer Prev. 5(Suppl 1):33–38.
   PubMed Web of Science ®Google Scholar
• Srinivas NR (2009). Dodging matrix effects in liquid chromatography tandem mass spectrometric assays—Compilation of key learnings and perspectives. Biomed Chromatogr. 23:451–454.
   PubMed Web of Science ®Google Scholar
• Stepanov I, Hecht SS (2005). Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users. Cancer Epidemiol Biomarkers Prev. 14:885–891.
   PubMed Web of Science ®Google Scholar
• Stepanov I, Hecht SS (2008). Detection and quantitation of N’-nitrosonornicotine in human toenails by liquid chromatography-electrospray ionization-tandem mass spectrometry. Cancer Epidemiol Biomarkers Prev. 17:945–948.
   PubMed Web of Science ®Google Scholar
• Stepanov I, Feuer R, Jensen J, Hatsukami D, Hecht SS (2006a). Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails. Cancer Epidemiol Biomarkers Prev. 15:2378–2383.
   PubMed Web of Science ®Google Scholar
• Stepanov I, Hecht SS, Duca G, Mardari I (2006b). Uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by Moldovan children. Cancer Epidemiol Biomarkers Prev. 15:7–11.
   PubMed Web of Science ®Google Scholar
• Stepanov I, Upadhyaya P, Carmella SG, Feuer R, Jensen J, Hatsukami DK, Hecht SS (2008). Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers. Cancer Epidemiol Biomarkers Prev. 17:1764–1773.
   PubMed Web of Science ®Google Scholar
• Sterner JL, Johnston MV, Nicol GR, Ridge DP (2000). Signal suppression in electrospray ionization Fourier transform mass spectrometry of multi-component samples. J Mass Spectrom. 35(3):385–391.
   PubMed Web of Science ®Google Scholar
• Stokvis E, Rosing H, Beijnen JH (2005). Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: Necessity or not? Rapid Commun Mass Spectrom. 19:401–407.
   PubMed Web of Science ®Google Scholar
• Swauger JE, Steichen TJ, Murphy PA, Kinsler S (2002). An analysis of the mainstream smoke chemistry of samples of the U.S. cigarette market acquired between 1995 and 2000. Regul Toxicol Pharmacol. 35(2 Pt 1):142–156.
   PubMed Web of Science ®Google Scholar
• Taioli E, Garbers S, Bradlow HL, Carmella SG, Akerkar S, Hecht SS (1997). Effects of indole-3-carbinol on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers. Cancer Epidemiol Biomarkers Prev. 6:517–522.
   PubMed Web of Science ®Google Scholar
• Taylor PJ (2005). Matrix effects: The Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem. 38:328–334.
   PubMed Web of Science ®Google Scholar
• Tricker AR, Ditrich C, Preussmann R (1991). N-nitroso compounds in cigarette tobacco and their occurrence in mainstream tobacco smoke. Carcinogenesis. 12:257–261.
   PubMed Web of Science ®Google Scholar
• Tricker AR, Scherer G, Conze C, Adlkofer F, Pachinger A, Klus H (1993). Evaluation of 4-(N-methylnitrosamino)-4-(3-pyridyl)butyric acid as a potential monitor of endogenous nitrosation of nicotine and its metabolites. Carcinogenesis. 14:1409–1414.
   PubMed Web of Science ®Google Scholar
• Tulunay OE, Hecht SS, Carmella SG, Zhang Y, Lemmonds C, Murphy S, Hatsukami DK (2005). Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers. Cancer Epidemiol Biomarkers Prev. 14:1283–1286.
   PubMed Web of Science ®Google Scholar
• Tyroller S, Zwickenpflug W, Richter E (2002). New sources of dietary myosmine uptake from cereals, fruits, vegetables, and milk. J Agric Food Chem 50:4909–4915.
   PubMed Web of Science ®Google Scholar
• Urban M, Scherer G, Kavvadias D, Hagedorn H-W, Feng S, Serafin R, Kapur S, Muhammad R, Jin Y, Mendes P, Roethig H (2009). Quantitation of N’-nitrosonornicotine (NNN) in smokers urine by liquid chromatography–tandem mass spectrometry. J Anal Toxicol 33:260–265.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services (2004). The Health Consequences of Smoking—A Report of the Surgeon General.
   Google Scholar
• US Food and Drug Administration (2001). Guidance for Industry—Bioanalytical Method Validation. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
   Google Scholar
• van Hout MW, Niederlander HA, de Zeeuw RA, de Jong GJ (2003). Ion suppression in the determination of clenbuterol in urine by solid-phase extraction atmospheric pressure chemical ionisation ion-trap mass spectrometry. Rapid Commun Mass Spectrom. 17:245–250.
   PubMed Web of Science ®Google Scholar
• Venn RF (2000) Principles and Practice of Bioanalysis. London: Taylor & Francis.
   Google Scholar
• Wang S, Cyronak M, Yang E (2007). Does a stable isotopically labeled internal standard always correct analyte response?: A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. J of Pharmaceut Biomed Anal 43:701–707.
   PubMed Web of Science ®Google Scholar
• Wild CP, Pisani P (1998). Carcinogen DNA and protein adducts as biomarkers of human exposure in environmental cancer epidemiology. Cancer Detect Prev. 22:273–283.
   PubMedGoogle Scholar
• Wu J, Joza P, Sharifi M, Rickert WS, Lauterbach JH (2008). Quantitative method for the analysis of tobacco-specific nitrosamines in cigarette tobacco and mainstream cigarette smoke by use of isotope dilution liquid chromatography tandem mass spectrometry. Anal Chem. 80:1341–1345.
   PubMed Web of Science ®Google Scholar
• Xia Y, McGuffey JE, Bhattacharyya S, Sellergren B, Yilmaz E, Wang L, Bernert JT (2005). Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Anal Chem. 77:7639–7645.
   PubMed Web of Science ®Google Scholar
• Xu RN, Fan L, Rieser MJ, El-Shourbagy TA (2007). Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. J Pharmceut Biomed Anal. 44:342–355.
   PubMed Web of Science ®Google Scholar
• Young DS (1987). Implementation of SI units for clinical laboratory data. Style specifications and conversion tables. Ann Intern Med. 106:114–129.
   PubMed Web of Science ®Google Scholar
• Yuan JM, Koh WP, Murphy SE, Fan Y, Wang R, Carmella SG, Han S, Wickham K, Gao YT, Yu MC, Hecht SS (2009). Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res. 69:2990–2995.
   PubMed Web of Science ®Google Scholar
• Zougagh M, Valcárcel M, Ríos A (2004). Supercritical fluid extraction: A critical review of its analytical usefulness. Trends Anal Chem 23:399–405.
   Web of Science ®Google Scholar
• Zwickenpflug W (2000). N-nitrosation of myosmine yields HPB (4-hydroxy-1-(3-pyridyl)-1-butanone) and NNN (N-nitrosonornicotine). J Agric Food Chem 48:392–394.
   PubMed Web of Science ®Google Scholar